EXALPHA PRODUCT CITATIONS

BrdU Immunohistochemistry Kit (Cat. No. X1545K)

1. Sato, S., et al. "Central control of bone remodeling by neuromedin U." Nature Medicine (2007), 13, 1234-1240.

BrdU Cell Proliferation Assay Kit (Cat. No. X1327K)

1. Nanakin, A., et al. "Expression of the REG IV gene in ulcerative cells." Laboratory Investigation (2007), 87, 304-314.
2. Chang, V., et al. "Adenoviral-mediated gene transfer of ectodysplasin-A2 results in induction of apoptosis and cell-cycle arrest in osteosarcoma cell lines." Cancer Gene Therapy (2007), 14, 927-933.
3. Sekine, C., et al. "Successful Treatment of Animal Models of Rheumatoid Arthritis with Small-Molecule Cyclin-Dependent Kinase Inhibitors." J. Immunol. (2008), 180, 1954-1961.
4. Matta, H., et al. "Activation of alternative NF-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP)." Proc. Natl. Acad. Sci. (2004), 101, 9399-9404.

Ceramide Glycosyltransferase (Cat. No. X1700P)

1. D'Angelo, G., et al. "Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide." Nature (2007), 449, 62-67.

Lysophosphatidic Acid Receptor

1. Shida, D., et al. "Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer." Laboratory Investigation (2004), 84, 1352-1362.

Sphingosine 1-Phosphate Receptor Antibodies

1. Goparaju, S.K., et al. "The S1P2 Receptor Negatively Regulates Platelet-Derived Growth Factor-Induced Motility and Proliferation." Mol. Cell. Biol. (2005), 25, 4237-4249.

Ion Channel Antibodies

1. Burkhalter, A., et al. "Differential Expression of IA Channel Subunits Kv4.2 and Kv4.3 in Mouse Visual Cortical Neurons and Synapses." J. Neurosci. (2006), 26, 12274-12282.
2. Luo, Z.D., et al. "Upregulation of Dorsal Root Ganglion alpha 2delta Calcium Channel Subunit and Its Correlation with Allodynia in Spinal Nerve-Injured Rats." J. Neurosci. (2001), 21, 1868-1875.

Chx10 Antibodies (Cat. No. X1179P & X1180P)

1. Qiu, F., et al. "A Comprehensive Negative Regulatory Program Controlled by Brn3b to Ensure Ganglion Cell Specification from Multipotential Retinal Precursors." J. Neurosci. (2008), 28, 3392-3403.
2. Elshatory, Y., et al. "Islet-1 Controls the Differentiation of Retinal Bipolar and Cholinergic Amacrine Cells." J. Neurosci. (2007), 27, 12707-12720.
3. Osakada, F., et al. "Wnt Signaling Promotes Regeneration in the Retina of Adult Mammals." J. Neurosci. (2007), 27, 4210-4219.

Vasoactive Intestinal Peptide Receptor Antibodies
1. Petkov, V., et al. "Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension." J. Clin. Invest. (2003), 111, 1339-1346.

Cyclooxygenase Antibodies

1. Kaneshiro, Y., et al. "Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats." Kidney International (2006), 70, 641-646.

LEF-1/TCF Antibodies

1. Denys, H., et al. "Identification of IGFBP-6 as a significantly downregulated gene by β-catenin in desmoid tumors." Oncogene (2004), 23, 654-664
2. Aoki, M., et al. "Oncogenic transformation by β-catenin: deletion analysis and characterization of selected target genes." Oncogene (2002), 21, 6983-6991.
3. Grueneberg, D.A., et al. "A Functional Screen in Human Cells Identifies UBF2 as an RNA Polymerase II Transcription Factor That Enhances the ß-Catenin Signaling Pathway." Mol. Cell. Biol. (2003), 23, 3936-3950.

PIG-3 Antibodies (Cat. No. X1155P & X1156M)

1. Marusyk, A., et al. "p53 mediates senescence-like arrest induced by chronic replicational stress." Mol. Cell. Bio. (2007), 27, 5336-5351.

Microphthalmia Antibody (Cat. No. X1405M)
1. Tshori, S., et al. "Transcription factor MITF regulates cardiac growth and hypertrophy." J. Clin. Invest. (2006), 116, 2673-2681.

Bax Antibody (Cat. No. A100M)

1. Annis, M., et al. "Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis." EMBO J. (2005), 24, 2096-2103.
2. Soucie, E.L., et al. "Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria." Mol. and Cell. Biol. (2001), 21, 4725-4736.

KSHV/HHV8 antibodies

1. Watanabe, T., et al. "Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells." J. Virol. (2003), 77, 6188-6196.

Collapsin Response Mediator Protein-1 (CRMP-1) (Cat. No. X1789P & X1790P)

1. Nilsen, J., et al. "Estradiol In Vivo Regulation of Brain Mitochondrial Proteome." J. Neurosci. (2007), 27, 14069-14077.

SNAP Antibodies

1. Chae, T., et al. "The hyh mutation uncovers roles for αSnap in apical protein localization and control of neural cell fate." Nature Genetics (2004), 36, 264-270.

EBNA3A, B & C antibodies (Cat. No. F115P, F120P, F125P)

1. Anderton, E., et al. "Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma." Oncogene (2007), 27, 421-433
2. O'Nions, J., et al. "Epstein–Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2." Oncogene (2003), 22, 7181-7191.
3. Jiménez-Ramírez, C., et al. "Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter." J. Virol. (2006), 80, 11200-11208.
4. Yuan, J., et al. "Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication." J. Virol. (2006), 80, 2548-2565.
5. Hong, G.K., et al. "Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model." J. Virol. (2005), 79, 13993-14003.
6. Rosendorff, A., et al. "EBNA3C Coactivation with EBNA2 Requires a SUMO Homology Domain." J. Virol. (2004), 78, 367-377.
7. Maruo, S., et al. "Epstein-Barr Virus Nuclear Protein EBNA3A Is Critical for Maintaining Lymphoblastoid Cell Line Growth." J. Virol. (2003), 77, 10437-10447.
8. Gordadze, A.V., et al. "Notch1IC Partially Replaces EBNA2 Function in B Cells Immortalized by Epstein-Barr Virus." J. Virol. (2001), 75, 5899-5912.
9. Dalbiès-Tran, R., et al. "Amino Acids of Epstein-Barr Virus Nuclear Antigen 3A Essential for Repression of Jkappa -Mediated Transcription and Their Evolutionary Conservation." J. Virol. (2001), 75, 90-99.

Caspase-12 Antibodies (Cat. No. X1114P & X1115P)

1. Hetz, C., et al. "Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein." EMBO J. (2003), 22, 5435-5445.
2. Hetz, C., et al. "The Disulfide Isomerase Grp58 Is a Protective Factor against Prion Neurotoxicity." J. Neurosci. (2005), 25, 2793-2802.

Farnesyl Antibody (Cat. No. X1165P)

1. Clase, A.C., et al. "The Pseudorabies Virus Us2 Protein, a Virion Tegument Component, Is Prenylated in Infected Cells." J. Virol. (2003), 77, 12285-12298.

P110 antibody (Cat. No. A115M)

1. Criollo, A., et al. "Regulation of autophagy by the inositol trisphosphate receptor." Cell Death and Differentiation (2007), 14, 1029-1039.

p27 antibody (Cat. No. C155M)

1. Vella, V., et al. "Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease." J. Clin. Endocrinol. Metab. (2004), 89, 2880-2889.

Protein Phosphatase antibodies

1. Maeda, T., et al. "Involvement of serine/threonine protein phosphatases sensitive to okadaic acid in restraint stress-induced hyperlocomotion in cocaine-sensitized mice." British Journal of Pharmacology (2006), 148, 405-412.
2. Chen, Z., et al. "Loss of Zap-70 and low molecular weight phosphotyrosine phosphatase occurs after therapy in a patient with B-chronic lymphocytic leukemia." Leukemia (2005), 19, 1503-1505.
3. Leung-Pineda, V., et al. "Phosphorylation of Chk1 by ATR Is Antagonized by a Chk1-Regulated Protein Phosphatase 2A Circuit." Mol. Cell. Biol. (2006), 26, 7529-7538.

CD56 Antibody (Cat. No. 0561)

1. Horikawa, M., et al. "Abnormal Natural Killer Cell Function in Systemic Sclerosis: Altered Cytokine Production and Defective Killing Activity." Journal of Investigative Dermatology (2005), 125, 731-737
2. Ishimoto, H., et al. "Midkine, a heparin-binding growth factor, selectively stimulates proliferation of definitive zone cells of the human fetal adrenal gland." J. Clin. Endocrinol. Metab. (2006), 91, 4050-4056.
3. Muench, M., et al. "Isolation of Definitive Zone and Chromaffin Cells Based upon Expression of CD56 (Neural Cell Adhesion Molecule) in the Human Fetal Adrenal Gland." J. Clin. Endocrinol. Metab. (2003), 88, 3921-3930.
4. Miles, L.A., et al. "Cell-Surface Actin Binds Plasminogen and Modulates Neurotransmitter Release from Catecholaminergic Cells." J. Neurosci. (2006), 26, 13017-13024.

Flow Cytometry

1. Bonetta, L. "Flow Cytomtry smaller and better." Nature Methods (2005), 2, 785-795.
2. Takebayashi, M., et al. "Blood dendritic cells are decreased in acute graft-versus-host disease." Bone Marrow Transplantation (2004), 33, 989-996.
3. Arpinati, M., et al. "Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation." Bone Marrow Transplantation (2002), 29, 887-891.
4. Kawabata, S., et al. "Induction of Th2 Cytokine Expression for p27-Specific IgA B Cell Responses after Targeted Lymph Node Immunization with Simian Immunodeficiency Virus Antigens in Rhesus Macaques." Journal of Infectious Diseases (1998), 177, 26-33.
5. Sauermann, U., et al. "Homozygosity for a Conserved Mhc Class II DQ-DRB Haplotype Is Associated with Rapid Disease Progression in Simian Immunodeficiency Virus–Infected Macaques: Results from a Prospective Study." Journal of Infectious Diseases (2000), 182, 716-724.
6. Heilmann, C., et al. "Staphylococcus aureus Fibronectin-Binding Protein (FnBP)–Mediated Adherence to Platelets, and Aggregation of Platelets Induced by FnBPA but Not by FnBPB." Journal of Infectious Diseases (2004), 190, 321-329.
7. O'Neill, E., et al. "Dynamic Evolution of the Human Immunodeficiency Virus Type 1 Pathogenic Factor, Nef." J. Virol. (2006), 80, 1311-1320.
8. Foster, J.L., et al. "Genetic and Functional Diversity of Human Immunodeficiency Virus Type 1 Subtype B Nef Primary Isolates." J. Virol. (2001) 75, 1672-1680.
9. Chakrabarti, L.A., et al. "Normal T-Cell Turnover in Sooty Mangabeys Harboring Active Simian Immunodeficiency Virus Infection." J. Virol. (2000), 74, 1209-1223.
10. Goldstein, S., et al. "Plateau Levels of Viremia Correlate with the Degree of CD4+-T-Cell Loss in Simian Immunodeficiency Virus SIVagm-Infected Pigtailed Macaques: Variable Pathogenicity of Natural SIVagm Isolates." J. Virol. (2005), 79, 5153-5162.
11. Chakrabarti, L.A., et al. "A Truncated Form of Nef Selected during Pathogenic Reversion of Simian Immunodeficiency Virus SIVmac239{Delta}nef Increases Viral Replication." J. Virol. (2003), 77, 1245-1256.
12. Chakrabarti, L.A., et al. " Properties of the Surface Envelope Glycoprotein Associated with Virulence of Simian-Human Immunodeficiency Virus SHIVSF33A Molecular Clones." J. Virol. (2002), 76, 1588-1599.
13. Cappelli, G., et al. " Human Macrophage Gamma Interferon Decreases Gene Expression but Not Replication of Mycobacterium tuberculosis: Analysis of the Host-Pathogen Reciprocal Influence on Transcription in a Comparison of Strains H37Rv and CMT97." Infect. Immun. (2001), 69, 7262-7270.
14. Luo, T., et al. "Human Immunodeficiency Virus Type 1 Nef-Induced CD4 Cell Surface Downregulation Is Inhibited by Ikarugamycin." J. Virol. (2001), 75, 2488-2492.
15. Weidmann, A., et al. "Proteolytic Cleavage of the Fusion Protein but Not Membrane Fusion Is Required for Measles Virus-Induced Immunosuppression In Vitro." J. Virol. (2000), 74, 1985-1993.
16. Anderson, S.J., et al. " The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef." J. Virol. (1994), 68, 3092-3101.

NuCycl Kits

1. Eriksson, M., et al. "Recurrent de novo point mutations in lamin A cause Hutchinson?Gilford progeria syndrome." Nature (2003), 423, 293-298.

Protein A & G Agarose gel

1. Abdullah, M., et al. "Killing of dsrA Mutants of Haemophilus ducreyi by Normal Human Serum Occurs via the Classical Complement Pathway and Is Initiated by Immunoglobulin M Binding." Infect. Immun. (2005), 73, 3431-3439.